Medical Care
Global Transdermal Drug Delivery System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 11, 25
- ID: 297722
- Pages: 157
- Figures: 146
- Views: 69
In 2024, the global market size of Transdermal Drug Delivery System was estimated to be worth US$ 19300 million and is forecast to reach approximately US$ 36200 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The transdermal drug delivery system (TDDS) market is driven by the increasing demand for non-invasive, convenient, and controlled drug administration methods. TDDS allows drugs to be delivered through the skin, bypassing the gastrointestinal tract and liver, which can reduce side effects and improve bioavailability. This method is especially beneficial for patients who have difficulty swallowing pills, those requiring continuous drug delivery, and individuals with chronic conditions like pain, hypertension, or diabetes. The market is also driven by advancements in technology, such as the development of better adhesive patches, microneedles, and nanocarriers, which enhance the efficiency and precision of drug delivery. These innovations are expanding the scope of TDDS applications, offering a wide range of therapeutic options.
Despite its growth, the transdermal drug delivery system market faces several challenges. One major limitation is the skin's barrier function, which restricts the absorption of larger or hydrophilic molecules, making it difficult to deliver certain drugs transdermally. Additionally, the high cost of developing and manufacturing TDDS products, as well as the need for specialized formulations, can deter smaller pharmaceutical companies from entering the market. Regulatory hurdles and concerns over the safety, efficacy, and long-term stability of transdermal formulations also present challenges. Furthermore, patient acceptance and the potential for skin irritation or allergic reactions to the adhesive components of TDDS patches may limit their widespread adoption.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transdermal Drug Delivery System in global and regional level.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Drug Delivery System revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The transdermal drug delivery system (TDDS) market is driven by the increasing demand for non-invasive, convenient, and controlled drug administration methods. TDDS allows drugs to be delivered through the skin, bypassing the gastrointestinal tract and liver, which can reduce side effects and improve bioavailability. This method is especially beneficial for patients who have difficulty swallowing pills, those requiring continuous drug delivery, and individuals with chronic conditions like pain, hypertension, or diabetes. The market is also driven by advancements in technology, such as the development of better adhesive patches, microneedles, and nanocarriers, which enhance the efficiency and precision of drug delivery. These innovations are expanding the scope of TDDS applications, offering a wide range of therapeutic options.
Despite its growth, the transdermal drug delivery system market faces several challenges. One major limitation is the skin's barrier function, which restricts the absorption of larger or hydrophilic molecules, making it difficult to deliver certain drugs transdermally. Additionally, the high cost of developing and manufacturing TDDS products, as well as the need for specialized formulations, can deter smaller pharmaceutical companies from entering the market. Regulatory hurdles and concerns over the safety, efficacy, and long-term stability of transdermal formulations also present challenges. Furthermore, patient acceptance and the potential for skin irritation or allergic reactions to the adhesive components of TDDS patches may limit their widespread adoption.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery System.
The Transdermal Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Transdermal Drug Delivery System in global and regional level.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Drug Delivery System revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Transdermal Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transdermal Drug Delivery System Market Size Estimates and Forecasts
2.2 Transdermal Drug Delivery System Market Size by Region: 2024 Versus 2031
2.2.1 Global Transdermal Drug Delivery System Revenue by Region: 2020-2025
2.2.2 Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031)
2.2.3 Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transdermal Drug Delivery System Revenue by Type (2020-2031)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transdermal Drug Delivery System Revenue by Application (2020-2031)
3.2.2 Global Transdermal Drug Delivery System Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Fentanyl of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.2 Nitroglycerin of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.3 Estradiol of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.4 Nicotine of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.5 Other of Transdermal Drug Delivery System Revenue Market Share by Application
4 Global Transdermal Drug Delivery System by Company
4.1 Global Transdermal Drug Delivery System Revenue by Company (2020-2025)
4.2 Global Transdermal Drug Delivery System Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Transdermal Drug Delivery System Companies around the World: Ranking by Revenue
4.3.2 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Transdermal Drug Delivery System Companies Headquarters & Product Type
4.4.1 Global Transdermal Drug Delivery System Companies Headquarters
4.4.2 Date of International Companies Enter into Transdermal Drug Delivery System Market
4.4.3 Global Transdermal Drug Delivery System Companies Product & Service
4.4.4 Fentanyl Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.5 Nitroglycerin Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.6 Estradiol Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.7 Nicotine Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.8 Other Revenue Market Share of Transdermal Drug Delivery System by Company
4.5 Global Transdermal Drug Delivery System Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hisamitsu
5.1.1 Hisamitsu Corporation Information
5.1.2 Hisamitsu Description, Business Overview
5.1.3 Hisamitsu Transdermal Drug Delivery System Products Offered
5.1.4 Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.1.5 Hisamitsu Transdermal Drug Delivery System Revenue by Product in 2024
5.1.6 Hisamitsu Transdermal Drug Delivery System Revenue by Application in 2024
5.1.7 Hisamitsu Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.1.8 Hisamitsu Recent Developments
5.2 Mylan
5.2.1 Mylan Corporation Information
5.2.2 Mylan Description, Business Overview
5.2.3 Mylan Transdermal Drug Delivery System Products Offered
5.2.4 Mylan Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.2.5 Mylan Transdermal Drug Delivery System Revenue by Product in 2024
5.2.6 Mylan Transdermal Drug Delivery System Revenue by Application in 2024
5.2.7 Mylan Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.2.8 Mylan Recent Developments
5.3 GSK
5.3.1 GSK Corporation Information
5.3.2 GSK Description, Business Overview
5.3.3 GSK Transdermal Drug Delivery System Products Offered
5.3.4 GSK Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.3.5 GSK Transdermal Drug Delivery System Revenue by Product in 2024
5.3.6 GSK Transdermal Drug Delivery System Revenue by Application in 2024
5.3.7 GSK Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.3.8 GSK Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Transdermal Drug Delivery System Products Offered
5.4.4 Novartis Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Transdermal Drug Delivery System Revenue by Product in 2024
5.4.6 Novartis Transdermal Drug Delivery System Revenue by Application in 2024
5.4.7 Novartis Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Teve (Actavis)
5.5.1 Teve (Actavis) Corporation Information
5.5.2 Teve (Actavis) Description, Business Overview
5.5.3 Teve (Actavis) Transdermal Drug Delivery System Products Offered
5.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.5.5 Teve (Actavis) Transdermal Drug Delivery System Revenue by Product in 2024
5.5.6 Teve (Actavis) Transdermal Drug Delivery System Revenue by Application in 2024
5.5.7 Teve (Actavis) Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.5.8 Teve (Actavis) Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Corporation Information
5.6.2 Johnson & Johnson Description, Business Overview
5.6.3 Johnson & Johnson Transdermal Drug Delivery System Products Offered
5.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.6.5 Johnson & Johnson Transdermal Drug Delivery System Revenue by Product in 2024
5.6.6 Johnson & Johnson Transdermal Drug Delivery System Revenue by Application in 2024
5.6.7 Johnson & Johnson Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.6.8 Johnson & Johnson Recent Developments
5.7 Lohmann
5.7.1 Lohmann Corporation Information
5.7.2 Lohmann Description, Business Overview
5.7.3 Lohmann Transdermal Drug Delivery System Products Offered
5.7.4 Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.7.5 Lohmann Transdermal Drug Delivery System Revenue by Product in 2024
5.7.6 Lohmann Transdermal Drug Delivery System Revenue by Application in 2024
5.7.7 Lohmann Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.7.8 Lohmann Recent Developments
5.8 Teikoku Seiyaku
5.8.1 Teikoku Seiyaku Corporation Information
5.8.2 Teikoku Seiyaku Description, Business Overview
5.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Products Offered
5.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.8.5 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Product in 2024
5.8.6 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Application in 2024
5.8.7 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.8.8 Teikoku Seiyaku Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Transdermal Drug Delivery System Products Offered
5.9.4 Bayer Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Transdermal Drug Delivery System Revenue by Product in 2024
5.9.6 Bayer Transdermal Drug Delivery System Revenue by Application in 2024
5.9.7 Bayer Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 Lingrui
5.10.1 Lingrui Corporation Information
5.10.2 Lingrui Description, Business Overview
5.10.3 Lingrui Transdermal Drug Delivery System Products Offered
5.10.4 Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.10.5 Lingrui Transdermal Drug Delivery System Revenue by Product in 2024
5.10.6 Lingrui Transdermal Drug Delivery System Revenue by Application in 2024
5.10.7 Lingrui Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.10.8 Lingrui Recent Developments
5.11 Sanofi
5.11.1 Sanofi Corporation Information
5.11.2 Sanofi Description, Business Overview
5.11.3 Sanofi Transdermal Drug Delivery System Products Offered
5.11.4 Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.11.5 Sanofi Transdermal Drug Delivery System Revenue by Product in 2024
5.11.6 Sanofi Transdermal Drug Delivery System Revenue by Application in 2024
5.11.7 Sanofi Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.11.8 Sanofi Recent Developments
5.12 Qizheng
5.12.1 Qizheng Corporation Information
5.12.2 Qizheng Description, Business Overview
5.12.3 Qizheng Transdermal Drug Delivery System Products Offered
5.12.4 Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.12.5 Qizheng Transdermal Drug Delivery System Revenue by Product in 2024
5.12.6 Qizheng Transdermal Drug Delivery System Revenue by Application in 2024
5.12.7 Qizheng Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.12.8 Qizheng Recent Developments
5.13 Endo
5.13.1 Endo Corporation Information
5.13.2 Endo Description, Business Overview
5.13.3 Endo Transdermal Drug Delivery System Products Offered
5.13.4 Endo Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.13.5 Endo Transdermal Drug Delivery System Revenue by Product in 2024
5.13.6 Endo Transdermal Drug Delivery System Revenue by Application in 2024
5.13.7 Endo Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.13.8 Endo Recent Developments
5.14 Huarun 999
5.14.1 Huarun 999 Corporation Information
5.14.2 Huarun 999 Description, Business Overview
5.14.3 Huarun 999 Transdermal Drug Delivery System Products Offered
5.14.4 Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.14.5 Huarun 999 Transdermal Drug Delivery System Revenue by Product in 2024
5.14.6 Huarun 999 Transdermal Drug Delivery System Revenue by Application in 2024
5.14.7 Huarun 999 Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.14.8 Huarun 999 Recent Developments
5.15 Haw Par
5.15.1 Haw Par Corporation Information
5.15.2 Haw Par Description, Business Overview
5.15.3 Haw Par Transdermal Drug Delivery System Products Offered
5.15.4 Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.15.5 Haw Par Transdermal Drug Delivery System Revenue by Product in 2024
5.15.6 Haw Par Transdermal Drug Delivery System Revenue by Application in 2024
5.15.7 Haw Par Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.15.8 Haw Par Recent Developments
5.16 Nichiban
5.16.1 Nichiban Corporation Information
5.16.2 Nichiban Description, Business Overview
5.16.3 Nichiban Transdermal Drug Delivery System Products Offered
5.16.4 Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.16.5 Nichiban Transdermal Drug Delivery System Revenue by Product in 2024
5.16.6 Nichiban Transdermal Drug Delivery System Revenue by Application in 2024
5.16.7 Nichiban Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.16.8 Nichiban Recent Developments
5.17 Mentholatum
5.17.1 Mentholatum Corporation Information
5.17.2 Mentholatum Description, Business Overview
5.17.3 Mentholatum Transdermal Drug Delivery System Products Offered
5.17.4 Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.17.5 Mentholatum Transdermal Drug Delivery System Revenue by Product in 2024
5.17.6 Mentholatum Transdermal Drug Delivery System Revenue by Application in 2024
5.17.7 Mentholatum Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.17.8 Mentholatum Recent Developments
5.18 Laboratoires Genevrier
5.18.1 Laboratoires Genevrier Corporation Information
5.18.2 Laboratoires Genevrier Description, Business Overview
5.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Products Offered
5.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.18.5 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Product in 2024
5.18.6 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Application in 2024
5.18.7 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.18.8 Laboratoires Genevrier Recent Developments
6 North America
6.1 North America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
6.2 North America Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
6.3 North America Transdermal Drug Delivery System Revenue by Type (2020-2025)
6.4 North America Transdermal Drug Delivery System Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transdermal Drug Delivery System Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Transdermal Drug Delivery System Revenue by Type (2020-2025)
7.4 Asia-Pacific Transdermal Drug Delivery System Revenue by Application (2020-2025)
8 Europe
8.1 Europe Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
8.2 Europe Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
8.3 Europe Transdermal Drug Delivery System Revenue by Type (2020-2025)
8.4 Europe Transdermal Drug Delivery System Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
9.2 Latin America Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
9.3 Latin America Transdermal Drug Delivery System Revenue by Type (2020-2025)
9.4 Latin America Transdermal Drug Delivery System Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Transdermal Drug Delivery System Revenue by Type (2020-2025)
10.4 Middle East and Africa Transdermal Drug Delivery System Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transdermal Drug Delivery System Supply Chain Analysis
11.2 Transdermal Drug Delivery System Key Raw Materials and Upstream Suppliers
11.3 Transdermal Drug Delivery System Clients Analysis
11.4 Transdermal Drug Delivery System Sales Channel and Sales Model Analysis
11.4.1 Transdermal Drug Delivery System Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transdermal Drug Delivery System Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transdermal Drug Delivery System Distributors
12 Transdermal Drug Delivery System Market Dynamics
12.1 Transdermal Drug Delivery System Industry Trends
12.2 Transdermal Drug Delivery System Market Drivers
12.3 Transdermal Drug Delivery System Market Challenges
12.4 Transdermal Drug Delivery System Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Transdermal Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Fentanyl
1.2.3 Nitroglycerin
1.2.4 Estradiol
1.2.5 Nicotine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 OTC
1.3.3 Rx
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Transdermal Drug Delivery System Market Size Estimates and Forecasts
2.2 Transdermal Drug Delivery System Market Size by Region: 2024 Versus 2031
2.2.1 Global Transdermal Drug Delivery System Revenue by Region: 2020-2025
2.2.2 Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031)
2.2.3 Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transdermal Drug Delivery System Revenue by Type (2020-2031)
3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transdermal Drug Delivery System Revenue by Application (2020-2031)
3.2.2 Global Transdermal Drug Delivery System Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Fentanyl of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.2 Nitroglycerin of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.3 Estradiol of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.4 Nicotine of Transdermal Drug Delivery System Revenue Market Share by Application
3.3.5 Other of Transdermal Drug Delivery System Revenue Market Share by Application
4 Global Transdermal Drug Delivery System by Company
4.1 Global Transdermal Drug Delivery System Revenue by Company (2020-2025)
4.2 Global Transdermal Drug Delivery System Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Transdermal Drug Delivery System Companies around the World: Ranking by Revenue
4.3.2 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Transdermal Drug Delivery System Companies Headquarters & Product Type
4.4.1 Global Transdermal Drug Delivery System Companies Headquarters
4.4.2 Date of International Companies Enter into Transdermal Drug Delivery System Market
4.4.3 Global Transdermal Drug Delivery System Companies Product & Service
4.4.4 Fentanyl Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.5 Nitroglycerin Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.6 Estradiol Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.7 Nicotine Revenue Market Share of Transdermal Drug Delivery System by Company
4.4.8 Other Revenue Market Share of Transdermal Drug Delivery System by Company
4.5 Global Transdermal Drug Delivery System Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hisamitsu
5.1.1 Hisamitsu Corporation Information
5.1.2 Hisamitsu Description, Business Overview
5.1.3 Hisamitsu Transdermal Drug Delivery System Products Offered
5.1.4 Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.1.5 Hisamitsu Transdermal Drug Delivery System Revenue by Product in 2024
5.1.6 Hisamitsu Transdermal Drug Delivery System Revenue by Application in 2024
5.1.7 Hisamitsu Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.1.8 Hisamitsu Recent Developments
5.2 Mylan
5.2.1 Mylan Corporation Information
5.2.2 Mylan Description, Business Overview
5.2.3 Mylan Transdermal Drug Delivery System Products Offered
5.2.4 Mylan Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.2.5 Mylan Transdermal Drug Delivery System Revenue by Product in 2024
5.2.6 Mylan Transdermal Drug Delivery System Revenue by Application in 2024
5.2.7 Mylan Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.2.8 Mylan Recent Developments
5.3 GSK
5.3.1 GSK Corporation Information
5.3.2 GSK Description, Business Overview
5.3.3 GSK Transdermal Drug Delivery System Products Offered
5.3.4 GSK Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.3.5 GSK Transdermal Drug Delivery System Revenue by Product in 2024
5.3.6 GSK Transdermal Drug Delivery System Revenue by Application in 2024
5.3.7 GSK Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.3.8 GSK Recent Developments
5.4 Novartis
5.4.1 Novartis Corporation Information
5.4.2 Novartis Description, Business Overview
5.4.3 Novartis Transdermal Drug Delivery System Products Offered
5.4.4 Novartis Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.4.5 Novartis Transdermal Drug Delivery System Revenue by Product in 2024
5.4.6 Novartis Transdermal Drug Delivery System Revenue by Application in 2024
5.4.7 Novartis Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.4.8 Novartis Recent Developments
5.5 Teve (Actavis)
5.5.1 Teve (Actavis) Corporation Information
5.5.2 Teve (Actavis) Description, Business Overview
5.5.3 Teve (Actavis) Transdermal Drug Delivery System Products Offered
5.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.5.5 Teve (Actavis) Transdermal Drug Delivery System Revenue by Product in 2024
5.5.6 Teve (Actavis) Transdermal Drug Delivery System Revenue by Application in 2024
5.5.7 Teve (Actavis) Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.5.8 Teve (Actavis) Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Corporation Information
5.6.2 Johnson & Johnson Description, Business Overview
5.6.3 Johnson & Johnson Transdermal Drug Delivery System Products Offered
5.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.6.5 Johnson & Johnson Transdermal Drug Delivery System Revenue by Product in 2024
5.6.6 Johnson & Johnson Transdermal Drug Delivery System Revenue by Application in 2024
5.6.7 Johnson & Johnson Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.6.8 Johnson & Johnson Recent Developments
5.7 Lohmann
5.7.1 Lohmann Corporation Information
5.7.2 Lohmann Description, Business Overview
5.7.3 Lohmann Transdermal Drug Delivery System Products Offered
5.7.4 Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.7.5 Lohmann Transdermal Drug Delivery System Revenue by Product in 2024
5.7.6 Lohmann Transdermal Drug Delivery System Revenue by Application in 2024
5.7.7 Lohmann Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.7.8 Lohmann Recent Developments
5.8 Teikoku Seiyaku
5.8.1 Teikoku Seiyaku Corporation Information
5.8.2 Teikoku Seiyaku Description, Business Overview
5.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Products Offered
5.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.8.5 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Product in 2024
5.8.6 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Application in 2024
5.8.7 Teikoku Seiyaku Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.8.8 Teikoku Seiyaku Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Transdermal Drug Delivery System Products Offered
5.9.4 Bayer Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Transdermal Drug Delivery System Revenue by Product in 2024
5.9.6 Bayer Transdermal Drug Delivery System Revenue by Application in 2024
5.9.7 Bayer Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 Lingrui
5.10.1 Lingrui Corporation Information
5.10.2 Lingrui Description, Business Overview
5.10.3 Lingrui Transdermal Drug Delivery System Products Offered
5.10.4 Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.10.5 Lingrui Transdermal Drug Delivery System Revenue by Product in 2024
5.10.6 Lingrui Transdermal Drug Delivery System Revenue by Application in 2024
5.10.7 Lingrui Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.10.8 Lingrui Recent Developments
5.11 Sanofi
5.11.1 Sanofi Corporation Information
5.11.2 Sanofi Description, Business Overview
5.11.3 Sanofi Transdermal Drug Delivery System Products Offered
5.11.4 Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.11.5 Sanofi Transdermal Drug Delivery System Revenue by Product in 2024
5.11.6 Sanofi Transdermal Drug Delivery System Revenue by Application in 2024
5.11.7 Sanofi Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.11.8 Sanofi Recent Developments
5.12 Qizheng
5.12.1 Qizheng Corporation Information
5.12.2 Qizheng Description, Business Overview
5.12.3 Qizheng Transdermal Drug Delivery System Products Offered
5.12.4 Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.12.5 Qizheng Transdermal Drug Delivery System Revenue by Product in 2024
5.12.6 Qizheng Transdermal Drug Delivery System Revenue by Application in 2024
5.12.7 Qizheng Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.12.8 Qizheng Recent Developments
5.13 Endo
5.13.1 Endo Corporation Information
5.13.2 Endo Description, Business Overview
5.13.3 Endo Transdermal Drug Delivery System Products Offered
5.13.4 Endo Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.13.5 Endo Transdermal Drug Delivery System Revenue by Product in 2024
5.13.6 Endo Transdermal Drug Delivery System Revenue by Application in 2024
5.13.7 Endo Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.13.8 Endo Recent Developments
5.14 Huarun 999
5.14.1 Huarun 999 Corporation Information
5.14.2 Huarun 999 Description, Business Overview
5.14.3 Huarun 999 Transdermal Drug Delivery System Products Offered
5.14.4 Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.14.5 Huarun 999 Transdermal Drug Delivery System Revenue by Product in 2024
5.14.6 Huarun 999 Transdermal Drug Delivery System Revenue by Application in 2024
5.14.7 Huarun 999 Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.14.8 Huarun 999 Recent Developments
5.15 Haw Par
5.15.1 Haw Par Corporation Information
5.15.2 Haw Par Description, Business Overview
5.15.3 Haw Par Transdermal Drug Delivery System Products Offered
5.15.4 Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.15.5 Haw Par Transdermal Drug Delivery System Revenue by Product in 2024
5.15.6 Haw Par Transdermal Drug Delivery System Revenue by Application in 2024
5.15.7 Haw Par Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.15.8 Haw Par Recent Developments
5.16 Nichiban
5.16.1 Nichiban Corporation Information
5.16.2 Nichiban Description, Business Overview
5.16.3 Nichiban Transdermal Drug Delivery System Products Offered
5.16.4 Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.16.5 Nichiban Transdermal Drug Delivery System Revenue by Product in 2024
5.16.6 Nichiban Transdermal Drug Delivery System Revenue by Application in 2024
5.16.7 Nichiban Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.16.8 Nichiban Recent Developments
5.17 Mentholatum
5.17.1 Mentholatum Corporation Information
5.17.2 Mentholatum Description, Business Overview
5.17.3 Mentholatum Transdermal Drug Delivery System Products Offered
5.17.4 Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.17.5 Mentholatum Transdermal Drug Delivery System Revenue by Product in 2024
5.17.6 Mentholatum Transdermal Drug Delivery System Revenue by Application in 2024
5.17.7 Mentholatum Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.17.8 Mentholatum Recent Developments
5.18 Laboratoires Genevrier
5.18.1 Laboratoires Genevrier Corporation Information
5.18.2 Laboratoires Genevrier Description, Business Overview
5.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Products Offered
5.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (2020-2025)
5.18.5 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Product in 2024
5.18.6 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Application in 2024
5.18.7 Laboratoires Genevrier Transdermal Drug Delivery System Revenue by Geographic Area in 2024
5.18.8 Laboratoires Genevrier Recent Developments
6 North America
6.1 North America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
6.2 North America Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
6.3 North America Transdermal Drug Delivery System Revenue by Type (2020-2025)
6.4 North America Transdermal Drug Delivery System Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transdermal Drug Delivery System Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Transdermal Drug Delivery System Revenue by Type (2020-2025)
7.4 Asia-Pacific Transdermal Drug Delivery System Revenue by Application (2020-2025)
8 Europe
8.1 Europe Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
8.2 Europe Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
8.3 Europe Transdermal Drug Delivery System Revenue by Type (2020-2025)
8.4 Europe Transdermal Drug Delivery System Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
9.2 Latin America Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
9.3 Latin America Transdermal Drug Delivery System Revenue by Type (2020-2025)
9.4 Latin America Transdermal Drug Delivery System Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transdermal Drug Delivery System Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transdermal Drug Delivery System Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Transdermal Drug Delivery System Revenue by Type (2020-2025)
10.4 Middle East and Africa Transdermal Drug Delivery System Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transdermal Drug Delivery System Supply Chain Analysis
11.2 Transdermal Drug Delivery System Key Raw Materials and Upstream Suppliers
11.3 Transdermal Drug Delivery System Clients Analysis
11.4 Transdermal Drug Delivery System Sales Channel and Sales Model Analysis
11.4.1 Transdermal Drug Delivery System Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transdermal Drug Delivery System Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transdermal Drug Delivery System Distributors
12 Transdermal Drug Delivery System Market Dynamics
12.1 Transdermal Drug Delivery System Industry Trends
12.2 Transdermal Drug Delivery System Market Drivers
12.3 Transdermal Drug Delivery System Market Challenges
12.4 Transdermal Drug Delivery System Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Transdermal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Transdermal Drug Delivery System Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Transdermal Drug Delivery System Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 11. Transdermal Drug Delivery System Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Transdermal Drug Delivery System Players by Revenue (US$ Million) in 2024
Table 13. Global Transdermal Drug Delivery System Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Table 15. Global Transdermal Drug Delivery System Companies Headquarters
Table 16. Date of International Companies Enter into Transdermal Drug Delivery System Market
Table 17. Global Transdermal Drug Delivery System Companies Product & Service
Table 18. Global Transdermal Drug Delivery System Mergers & Acquisitions, Expansion Plans
Table 19. Hisamitsu Corporation Information
Table 20. Hisamitsu Description and Business Overview
Table 21. Hisamitsu Transdermal Drug Delivery System Product
Table 22. Hisamitsu Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 24. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 25. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 26. Hisamitsu Recent Developments
Table 27. Mylan Corporation Information
Table 28. Mylan Description and Business Overview
Table 29. Mylan Transdermal Drug Delivery System Product
Table 30. Mylan Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Mylan Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 32. Mylan Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 33. Mylan Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 34. Mylan Recent Developments
Table 35. GSK Corporation Information
Table 36. GSK Description and Business Overview
Table 37. GSK Transdermal Drug Delivery System Product
Table 38. GSK Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. GSK Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 40. GSK Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 41. GSK Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 42. GSK Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Transdermal Drug Delivery System Product
Table 46. Novartis Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 48. Novartis Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 49. Novartis Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Teve (Actavis) Corporation Information
Table 52. Teve (Actavis) Description and Business Overview
Table 53. Teve (Actavis) Transdermal Drug Delivery System Product
Table 54. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 56. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 57. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 58. Teve (Actavis) Recent Developments
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Transdermal Drug Delivery System Product
Table 62. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 64. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 65. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 66. Johnson & Johnson Recent Developments
Table 67. Lohmann Corporation Information
Table 68. Lohmann Description and Business Overview
Table 69. Lohmann Transdermal Drug Delivery System Product
Table 70. Lohmann Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 72. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 73. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 74. Lohmann Recent Developments
Table 75. Teikoku Seiyaku Corporation Information
Table 76. Teikoku Seiyaku Description and Business Overview
Table 77. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 78. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 80. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 81. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 82. Teikoku Seiyaku Recent Developments
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Transdermal Drug Delivery System Product
Table 86. Bayer Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Bayer Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 88. Bayer Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 89. Bayer Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 90. Bayer Recent Developments
Table 91. Lingrui Corporation Information
Table 92. Lingrui Description and Business Overview
Table 93. Lingrui Transdermal Drug Delivery System Product
Table 94. Lingrui Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 96. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 97. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 98. Lingrui Recent Developments
Table 99. Sanofi Corporation Information
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi Transdermal Drug Delivery System Product
Table 102. Sanofi Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 104. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 105. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 106. Sanofi Recent Developments
Table 107. Qizheng Corporation Information
Table 108. Qizheng Description and Business Overview
Table 109. Qizheng Transdermal Drug Delivery System Product
Table 110. Qizheng Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 112. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 113. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 114. Qizheng Recent Developments
Table 115. Endo Corporation Information
Table 116. Endo Description and Business Overview
Table 117. Endo Transdermal Drug Delivery System Product
Table 118. Endo Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Endo Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 120. Endo Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 121. Endo Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 122. Endo Recent Developments
Table 123. Huarun 999 Corporation Information
Table 124. Huarun 999 Description and Business Overview
Table 125. Huarun 999 Transdermal Drug Delivery System Product
Table 126. Huarun 999 Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 128. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 129. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 130. Huarun 999 Recent Developments
Table 131. Haw Par Corporation Information
Table 132. Haw Par Description and Business Overview
Table 133. Haw Par Transdermal Drug Delivery System Product
Table 134. Haw Par Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 136. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 137. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 138. Haw Par Recent Developments
Table 139. Nichiban Corporation Information
Table 140. Nichiban Description and Business Overview
Table 141. Nichiban Transdermal Drug Delivery System Product
Table 142. Nichiban Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 144. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 145. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 146. Nichiban Recent Developments
Table 147. Mentholatum Corporation Information
Table 148. Mentholatum Description and Business Overview
Table 149. Mentholatum Transdermal Drug Delivery System Product
Table 150. Mentholatum Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 152. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 153. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 154. Mentholatum Recent Developments
Table 155. Laboratoires Genevrier Corporation Information
Table 156. Laboratoires Genevrier Description and Business Overview
Table 157. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 158. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 160. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 161. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 162. Laboratoires Genevrier Recent Developments
Table 163. North America Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Transdermal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Transdermal Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 183. Transdermal Drug Delivery System Key Raw Materials, Industry Status and Trend
Table 184. Transdermal Drug Delivery System Key Raw Materials and Upstream Suppliers
Table 185. Transdermal Drug Delivery System Clients Status and Trend
Table 186. Transdermal Drug Delivery System Typical Clients
Table 187. Transdermal Drug Delivery System Distributors
Table 188. Transdermal Drug Delivery System Market Trends
Table 189. Transdermal Drug Delivery System Market Drivers
Table 190. Transdermal Drug Delivery System Market Challenges
Table 191. Transdermal Drug Delivery System Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Delivery System Product Picture
Figure 2. Global Transdermal Drug Delivery System Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Transdermal Drug Delivery System Revenue Market Share by Type in 2024 & 2031
Figure 4. Fentanyl Product Picture
Figure 5. Nitroglycerin Product Picture
Figure 6. Estradiol Product Picture
Figure 7. Nicotine Product Picture
Figure 8. Other Product Picture
Figure 9. Global Transdermal Drug Delivery System Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Transdermal Drug Delivery System Revenue Market Share by Application in 2024 & 2031
Figure 11. OTC
Figure 12. Rx
Figure 13. Transdermal Drug Delivery System Report Years Considered
Figure 14. Global Transdermal Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transdermal Drug Delivery System Market Size (2020-2031) & (US$ Million)
Figure 16. Global Transdermal Drug Delivery System Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
Figure 18. Global Transdermal Drug Delivery System Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Transdermal Drug Delivery System Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Fentanyl of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 21. Nitroglycerin of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 22. Estradiol of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 23. Nicotine of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 24. Other of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 25. Transdermal Drug Delivery System Revenue Share by Company (2024)
Figure 26. Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Fentanyl Revenue Proportion by Company in 2024
Figure 28. Nitroglycerin Revenue Proportion by Company in 2024
Figure 29. Estradiol Revenue Proportion by Company in 2024
Figure 30. Nicotine Revenue Proportion by Company in 2024
Figure 31. Other Revenue Proportion by Company in 2024
Figure 32. North America Transdermal Drug Delivery System Revenue 2020-2031 (US$ Million)
Figure 33. North America Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 34. North America Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Transdermal Drug Delivery System Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 39. Europe Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 41. Europe Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 42. Europe Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 51. Transdermal Drug Delivery System Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Transdermal Drug Delivery System Raw Materials by Region in 2024
Figure 53. Transdermal Drug Delivery System Distribution Channels
Figure 54. Global Transdermal Drug Delivery System Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Transdermal Drug Delivery System Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Transdermal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Transdermal Drug Delivery System Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Transdermal Drug Delivery System Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Transdermal Drug Delivery System Revenue by Company (2020-2025) & (US$ Million)
Table 11. Transdermal Drug Delivery System Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Transdermal Drug Delivery System Players by Revenue (US$ Million) in 2024
Table 13. Global Transdermal Drug Delivery System Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Transdermal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2024)
Table 15. Global Transdermal Drug Delivery System Companies Headquarters
Table 16. Date of International Companies Enter into Transdermal Drug Delivery System Market
Table 17. Global Transdermal Drug Delivery System Companies Product & Service
Table 18. Global Transdermal Drug Delivery System Mergers & Acquisitions, Expansion Plans
Table 19. Hisamitsu Corporation Information
Table 20. Hisamitsu Description and Business Overview
Table 21. Hisamitsu Transdermal Drug Delivery System Product
Table 22. Hisamitsu Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 24. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 25. Hisamitsu Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 26. Hisamitsu Recent Developments
Table 27. Mylan Corporation Information
Table 28. Mylan Description and Business Overview
Table 29. Mylan Transdermal Drug Delivery System Product
Table 30. Mylan Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Mylan Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 32. Mylan Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 33. Mylan Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 34. Mylan Recent Developments
Table 35. GSK Corporation Information
Table 36. GSK Description and Business Overview
Table 37. GSK Transdermal Drug Delivery System Product
Table 38. GSK Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. GSK Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 40. GSK Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 41. GSK Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 42. GSK Recent Developments
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Transdermal Drug Delivery System Product
Table 46. Novartis Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Novartis Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 48. Novartis Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 49. Novartis Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 50. Novartis Recent Developments
Table 51. Teve (Actavis) Corporation Information
Table 52. Teve (Actavis) Description and Business Overview
Table 53. Teve (Actavis) Transdermal Drug Delivery System Product
Table 54. Teve (Actavis) Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 56. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 57. Teve (Actavis) Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 58. Teve (Actavis) Recent Developments
Table 59. Johnson & Johnson Corporation Information
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson Transdermal Drug Delivery System Product
Table 62. Johnson & Johnson Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 64. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 65. Johnson & Johnson Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 66. Johnson & Johnson Recent Developments
Table 67. Lohmann Corporation Information
Table 68. Lohmann Description and Business Overview
Table 69. Lohmann Transdermal Drug Delivery System Product
Table 70. Lohmann Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 72. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 73. Lohmann Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 74. Lohmann Recent Developments
Table 75. Teikoku Seiyaku Corporation Information
Table 76. Teikoku Seiyaku Description and Business Overview
Table 77. Teikoku Seiyaku Transdermal Drug Delivery System Product
Table 78. Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 80. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 81. Teikoku Seiyaku Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 82. Teikoku Seiyaku Recent Developments
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Transdermal Drug Delivery System Product
Table 86. Bayer Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Bayer Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 88. Bayer Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 89. Bayer Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 90. Bayer Recent Developments
Table 91. Lingrui Corporation Information
Table 92. Lingrui Description and Business Overview
Table 93. Lingrui Transdermal Drug Delivery System Product
Table 94. Lingrui Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 96. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 97. Lingrui Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 98. Lingrui Recent Developments
Table 99. Sanofi Corporation Information
Table 100. Sanofi Description and Business Overview
Table 101. Sanofi Transdermal Drug Delivery System Product
Table 102. Sanofi Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 104. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 105. Sanofi Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 106. Sanofi Recent Developments
Table 107. Qizheng Corporation Information
Table 108. Qizheng Description and Business Overview
Table 109. Qizheng Transdermal Drug Delivery System Product
Table 110. Qizheng Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 112. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 113. Qizheng Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 114. Qizheng Recent Developments
Table 115. Endo Corporation Information
Table 116. Endo Description and Business Overview
Table 117. Endo Transdermal Drug Delivery System Product
Table 118. Endo Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Endo Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 120. Endo Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 121. Endo Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 122. Endo Recent Developments
Table 123. Huarun 999 Corporation Information
Table 124. Huarun 999 Description and Business Overview
Table 125. Huarun 999 Transdermal Drug Delivery System Product
Table 126. Huarun 999 Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 128. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 129. Huarun 999 Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 130. Huarun 999 Recent Developments
Table 131. Haw Par Corporation Information
Table 132. Haw Par Description and Business Overview
Table 133. Haw Par Transdermal Drug Delivery System Product
Table 134. Haw Par Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 135. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 136. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 137. Haw Par Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 138. Haw Par Recent Developments
Table 139. Nichiban Corporation Information
Table 140. Nichiban Description and Business Overview
Table 141. Nichiban Transdermal Drug Delivery System Product
Table 142. Nichiban Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 144. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 145. Nichiban Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 146. Nichiban Recent Developments
Table 147. Mentholatum Corporation Information
Table 148. Mentholatum Description and Business Overview
Table 149. Mentholatum Transdermal Drug Delivery System Product
Table 150. Mentholatum Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 151. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 152. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 153. Mentholatum Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 154. Mentholatum Recent Developments
Table 155. Laboratoires Genevrier Corporation Information
Table 156. Laboratoires Genevrier Description and Business Overview
Table 157. Laboratoires Genevrier Transdermal Drug Delivery System Product
Table 158. Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$ Million) and Gross Margin (2020-2025)
Table 159. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Product in 2024
Table 160. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Application in 2024
Table 161. Laboratoires Genevrier Revenue Proportion of Transdermal Drug Delivery System by Geographic Area in 2024
Table 162. Laboratoires Genevrier Recent Developments
Table 163. North America Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 164. North America Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 165. North America Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 166. North America Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 167. Asia-Pacific Transdermal Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
Table 168. Asia-Pacific Transdermal Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
Table 169. Asia-Pacific Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 170. Asia-Pacific Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 171. Europe Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 172. Europe Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 173. Europe Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 174. Europe Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 175. Latin America Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 176. Latin America Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 177. Latin America Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 178. Latin America Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 179. Middle East and Africa Transdermal Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
Table 180. Middle East and Africa Transdermal Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
Table 181. Middle East and Africa Transdermal Drug Delivery System Revenue by Type (2020-2025) & (US$ Million)
Table 182. Middle East and Africa Transdermal Drug Delivery System Revenue by Application (2020-2025) & (US$ Million)
Table 183. Transdermal Drug Delivery System Key Raw Materials, Industry Status and Trend
Table 184. Transdermal Drug Delivery System Key Raw Materials and Upstream Suppliers
Table 185. Transdermal Drug Delivery System Clients Status and Trend
Table 186. Transdermal Drug Delivery System Typical Clients
Table 187. Transdermal Drug Delivery System Distributors
Table 188. Transdermal Drug Delivery System Market Trends
Table 189. Transdermal Drug Delivery System Market Drivers
Table 190. Transdermal Drug Delivery System Market Challenges
Table 191. Transdermal Drug Delivery System Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Delivery System Product Picture
Figure 2. Global Transdermal Drug Delivery System Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Transdermal Drug Delivery System Revenue Market Share by Type in 2024 & 2031
Figure 4. Fentanyl Product Picture
Figure 5. Nitroglycerin Product Picture
Figure 6. Estradiol Product Picture
Figure 7. Nicotine Product Picture
Figure 8. Other Product Picture
Figure 9. Global Transdermal Drug Delivery System Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 10. Global Transdermal Drug Delivery System Revenue Market Share by Application in 2024 & 2031
Figure 11. OTC
Figure 12. Rx
Figure 13. Transdermal Drug Delivery System Report Years Considered
Figure 14. Global Transdermal Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transdermal Drug Delivery System Market Size (2020-2031) & (US$ Million)
Figure 16. Global Transdermal Drug Delivery System Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
Figure 18. Global Transdermal Drug Delivery System Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Transdermal Drug Delivery System Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Fentanyl of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 21. Nitroglycerin of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 22. Estradiol of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 23. Nicotine of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 24. Other of Transdermal Drug Delivery System Revenue Market Share by Application, 2024 VS 2031
Figure 25. Transdermal Drug Delivery System Revenue Share by Company (2024)
Figure 26. Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Fentanyl Revenue Proportion by Company in 2024
Figure 28. Nitroglycerin Revenue Proportion by Company in 2024
Figure 29. Estradiol Revenue Proportion by Company in 2024
Figure 30. Nicotine Revenue Proportion by Company in 2024
Figure 31. Other Revenue Proportion by Company in 2024
Figure 32. North America Transdermal Drug Delivery System Revenue 2020-2031 (US$ Million)
Figure 33. North America Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 34. North America Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 35. Asia-Pacific Transdermal Drug Delivery System Revenue 2020-2031 (US$ Million)
Figure 36. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 39. Europe Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 41. Europe Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 42. Europe Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 43. Latin America Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Latin America Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 45. Latin America Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 46. Latin America Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 47. Middle East and Africa Transdermal Drug Delivery System Revenue Growth Rate 2020-2031 (US$ Million)
Figure 48. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Transdermal Drug Delivery System Revenue Market Share by Application (2020-2025)
Figure 51. Transdermal Drug Delivery System Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Transdermal Drug Delivery System Raw Materials by Region in 2024
Figure 53. Transdermal Drug Delivery System Distribution Channels
Figure 54. Global Transdermal Drug Delivery System Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Transdermal Drug Delivery System Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232